MaxPro Medical
MaxPro Medical
Obstructive Sleep Apnea (OSA) has emerged as one of the most prevalent yet underdiagnosed chronic conditions globally, affecting over 1 billion adults aged 30-69. As a leading China Sleep Apnea Monitor Factory, MaxPro Medical has witnessed a paradigm shift from traditional, cumbersome in-lab Polysomnography (PSG) to sophisticated Home Sleep Testing (HST) solutions. This transition is driven by the need for cost-effective, scalable, and patient-centric diagnostic tools.
Modern Sleep Apnea monitors now integrate multi-modal sensors—combining SpO2, heart rate variability (HRV), respiratory effort, and nasal airflow—into wearable form factors. This "Information Gain" in data collection allows clinicians to identify not just the presence of apnea, but its physiological phenotypes, leading to more personalized treatment pathways such as CPAP titration or oral appliance therapy.
Leveraging machine learning algorithms to filter artifacts and automatically score respiratory events with 95%+ accuracy compared to manual scoring.
Shifting from bedside consoles to wrist-worn and ring-style monitors that improve patient compliance during multi-night studies.
Real-time data synchronization with mobile APPs and hospital HMS for remote patient management (RPM).
Establishing the Gold Standard in Chronic Disease Monitoring Since 2009
Founded in 2009, Shenzhen MaxPro Medical Co., Ltd. is a leading manufacturer specializing in advanced medical devices and chronic disease monitoring solutions. With a strong commitment to innovation, quality, and customer satisfaction, we provide reliable healthcare technologies to over 500 healthcare institutions and distributors worldwide.
Our mission is to empower healthcare professionals with dependable medical technologies that improve patient outcomes and enhance healthcare efficiency worldwide. We uphold core values of Quality First, Customer Focus, and Innovation.
ISO 13485 Certified Production & Strict Quality Control Protocols
For international buyers and medical distributors, selecting a Sleep Apnea Monitor supplier involves rigorous due diligence. We understand that procurement is not just about the device—it’s about the entire lifecycle support, clinical validation, and regulatory compliance.
Our products adhere to EU MDR (2017/745) and FDA 510(k) requirements. We provide full Technical Documentation (TD) to assist our partners in local registrations.
In a post-pandemic era, we offer buffered inventory and vertical integration to mitigate the risks of semiconductor shortages in medical sensors.
Compliance with GDPR and HIPAA is non-negotiable. Our software solutions feature end-to-end encryption for patient data transmitted via Bluetooth or Wi-Fi.
The next frontier for Sleep Apnea monitors is the transition from *diagnostic* to *predictive*. By integrating AI that analyzes longitudinal data over months, we can predict the onset of cardiovascular complications or stroke risks associated with untreated apnea. MaxPro Medical's R&D is currently focusing on Contactless Monitoring—using radar-based sensing to monitor vital signs without any wearables, ensuring 100% patient comfort.
Type III devices measure at least 4 parameters (airflow, SpO2, heart rate, and respiratory effort), making them suitable for clinical diagnosis. Type IV monitors (like our wrist-worn BM2000A) typically focus on SpO2 and pulse rate, serving as excellent screening tools for high-risk populations.
Yes. We provide comprehensive SDK/API documentation for our Bluetooth-enabled devices, allowing seamless integration into hospital management systems or customized telehealth applications.
Our SpO2 sensors undergo multi-point calibration against clinical-grade reference monitors. We use high-performance photodetectors that maintain accuracy even during motion or low perfusion (PI < 0.2%).
